Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Influenza and sepsis: Mayo expert describes warning signs of severe sepsis, septic shock

14.01.2015

Sepsis can be a dangerous complication of almost any type of infection, including influenza, pneumonia and food poisoning; urinary tract infections; bloodstream infections from wounds; and abdominal infections.

Steve Peters, M.D., a pulmonary and critical care physician at Mayo Clinic and senior author of a recent sepsis overview in the medical journal Mayo Clinic Proceedings, explains sepsis symptoms and risk factors, the difference between severe sepsis and septic shock, and how sepsis is typically treated:

What is sepsis? Sepsis occurs when chemicals released into the bloodstream to fight an infection trigger inflammatory responses throughout the body. This inflammation can trigger a cascade of changes that can damage multiple organ systems, causing them to fail.

"Many infections can cause it," Dr. Peters says. "It is most common with bacterial infections, but you can get sepsis from other types of bugs also."

What are symptoms to watch for? A high fever; inability to keep fluids down; rapid heartbeat; rapid, shallow breathing; lethargy and confusion are among the signs. If sepsis is suspected, seek emergency care, Dr. Peters advises. Rapid intervention is critical.

"Let's say one feels some nasal congestion, and achy, like a cold or upper respiratory illness they'd had many times before, or a low-grade temperature of 99 or 100 F, and otherwise they're up and around and able to drink fluids: That would not call for going to the emergency department," he says. "But, if one was not able to take fluids, became more sleepy and lethargic and was lying down all day, and starting to look quite ill or appearing confused, for example -- that person should definitely be seen by a doctor."

How is sepsis treated? The first step is diagnosis: Cultures are taken from the blood and any other relevant parts of the body. Intravenous fluids are given, and antibiotics are usually started right away.

"Probably the single most important thing is to try to maintain fluids," Dr. Peters says. "The damage of sepsis probably begins with loss of fluids."

If sepsis is severe, with rapid heart rate, rapid breathing and shortness of breath, and the initial fluid given doesn't prompt rapid improvement, patients are usually hospitalized.

What are the differences among sepsis, severe sepsis and septic shock? Sepsis refers to signs of inflammation in the presence of a presumed infection, Dr. Peters says.

"Severe sepsis means you've got that and signs of organ damage: lung injury, impaired kidney function, impaired liver function," Dr. Peters explains. "Septic shock means you have all of those findings of severe sepsis, but now you've been given fluids, and there's still poor blood pressure, poor urine output, breathing troubles, and there are still ongoing signs of sepsis."

Septic shock can be fatal. Among hospitalized patients, septic shock is associated with a 20 to 30 percent risk of death, Dr. Peters says.

Sepsis is such a concern in hospital critical care units that Mayo Clinic has developed a sepsis "sniffer" to help detect it in patients and spot who is at higher risk. Recent improvements to the sniffer are outlined in a new article in Mayo Clinic Proceedings.

Who's at risk? Anyone can develop sepsis. People on chemotherapy or other immune-suppressing drugs are at higher risk, as are the elderly and people with open wounds that could lead to infection. Often, immune-suppressed patients are given antibiotics preventively.

Is there anything you can do to prevent sepsis if you catch the flu or another illness?

"Taking your temperature is important, because it gives a good assessment of how severe this might be," Dr. Peters says. "Probably the single most important thing is to try to continue taking in fluids. Watch for signs and symptoms, and seek urgent medical care if you suspect sepsis."

###

For interviews with Dr. Peters, please contact Sharon Theimer in Mayo Clinic Public Affairs at 507-284-5005 or newsbureau@mayo.edu.

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit http://mayocl.in/1ohJTMS, or http://newsnetwork.mayoclinic.org/.

About Mayo Clinic Proceedings

Mayo Clinic Proceedings is a monthly peer-reviewed medical journal that publishes original articles and reviews dealing with clinical and laboratory medicine, clinical research, basic science research and clinical epidemiology. Proceedings is sponsored by the Mayo Foundation for Medical Education and Research as part of its commitment to physician education. It publishes submissions from authors worldwide. The journal has been published for more than 80 years and has a circulation of 130,000. Articles are available online at http://www.mayoclinicproceedings.org

Media Contact

Sharon Theimer
newsbureau@email.com
507-284-5005

 @MayoClinic

http://www.mayoclinic.org/news 

Sharon Theimer | EurekAlert!

Further reports about: Influenza Sepsis antibiotics damage fluids function septic septic shock symptoms warning signs

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>